In situ engineering of the lymph node microenvironment via intranodal injection of adjuvant-releasing polymer particles
Recent studies have demonstrated a simple, potentially universal strategy to enhance vaccine potency, via intralymph node (i.LN) injection. To date, intranodal immunization studies have focused on the delivery of unadjuvanted vaccines (e.g., naked DNA, peptide, or protein). We hypothesized that comb...
| Main Authors: | , , |
|---|---|
| Other Authors: | |
| Format: | Article |
| Language: | en_US |
| Published: |
National Academy of Sciences
2012
|
| Online Access: | http://hdl.handle.net/1721.1/70020 |
| _version_ | 1826188961661321216 |
|---|---|
| author | Jewell, Christopher M. Irvine, Darrell J Bustamante Lopez, Sandra C |
| author2 | Massachusetts Institute of Technology. Department of Biological Engineering |
| author_facet | Massachusetts Institute of Technology. Department of Biological Engineering Jewell, Christopher M. Irvine, Darrell J Bustamante Lopez, Sandra C |
| author_sort | Jewell, Christopher M. |
| collection | MIT |
| description | Recent studies have demonstrated a simple, potentially universal strategy to enhance vaccine potency, via intralymph node (i.LN) injection. To date, intranodal immunization studies have focused on the delivery of unadjuvanted vaccines (e.g., naked DNA, peptide, or protein). We hypothesized that combining i.LN vaccination with controlled release biomaterials permitting sustained dosing of molecular adjuvants to the local tissue microenvironment would further enhance this promising vaccination strategy. To test this idea, we encapsulated the Toll-like receptor-3 ligand poly(inosinic:cytidylic acid) (polyIC) in biodegradable poly(lactide-co-glycolide) microparticles (MPs) designed to remain extracellular and release polyIC in the LN over several days. Intranodal injection of MPs increased persistence of polyIC in LNs compared to the same dose of soluble polyIC or polyIC formulated in nanoparticles, leading to increased accumulation of Toll-like receptor agonist in LN-resident antigen presenting cells and more enduring dendritic cell activation. Intralymph node injection of ovalbumin mixed with polyIC-releasing MPs enhanced the humoral response and expanded ovalbumin-specific T cells to frequencies as high as 18% among all CD8[superscript +] cells following a single injection (8.2-fold greater than the same vaccine given i.m.), a response that could not be matched by antigen mixed with polyIC-loaded nanoparticles or a 10-fold greater dose of soluble polyIC. Thus, i.LN immunization with slow release-formulated adjuvants may be a broadly applicable strategy to enhance therapeutic or prophylactic vaccines. |
| first_indexed | 2024-09-23T08:07:41Z |
| format | Article |
| id | mit-1721.1/70020 |
| institution | Massachusetts Institute of Technology |
| language | en_US |
| last_indexed | 2024-09-23T08:07:41Z |
| publishDate | 2012 |
| publisher | National Academy of Sciences |
| record_format | dspace |
| spelling | mit-1721.1/700202022-09-30T07:42:25Z In situ engineering of the lymph node microenvironment via intranodal injection of adjuvant-releasing polymer particles Jewell, Christopher M. Irvine, Darrell J Bustamante Lopez, Sandra C Massachusetts Institute of Technology. Department of Biological Engineering Massachusetts Institute of Technology. Department of Materials Science and Engineering Ragon Institute of MGH, MIT and Harvard Koch Institute for Integrative Cancer Research at MIT Irvine, Darrell J. Jewell, Christopher M. Bustamante Lopez, Sandra C. Irvine, Darrell J. Recent studies have demonstrated a simple, potentially universal strategy to enhance vaccine potency, via intralymph node (i.LN) injection. To date, intranodal immunization studies have focused on the delivery of unadjuvanted vaccines (e.g., naked DNA, peptide, or protein). We hypothesized that combining i.LN vaccination with controlled release biomaterials permitting sustained dosing of molecular adjuvants to the local tissue microenvironment would further enhance this promising vaccination strategy. To test this idea, we encapsulated the Toll-like receptor-3 ligand poly(inosinic:cytidylic acid) (polyIC) in biodegradable poly(lactide-co-glycolide) microparticles (MPs) designed to remain extracellular and release polyIC in the LN over several days. Intranodal injection of MPs increased persistence of polyIC in LNs compared to the same dose of soluble polyIC or polyIC formulated in nanoparticles, leading to increased accumulation of Toll-like receptor agonist in LN-resident antigen presenting cells and more enduring dendritic cell activation. Intralymph node injection of ovalbumin mixed with polyIC-releasing MPs enhanced the humoral response and expanded ovalbumin-specific T cells to frequencies as high as 18% among all CD8[superscript +] cells following a single injection (8.2-fold greater than the same vaccine given i.m.), a response that could not be matched by antigen mixed with polyIC-loaded nanoparticles or a 10-fold greater dose of soluble polyIC. Thus, i.LN immunization with slow release-formulated adjuvants may be a broadly applicable strategy to enhance therapeutic or prophylactic vaccines. Massachusetts Institute of Technology. Ragon Institute of MGH, MIT and Harvard (Ragon Institute Postdoctoral Fellow) Howard Hughes Medical Institute (Investigator) 2012-04-13T16:47:46Z 2012-04-13T16:47:46Z 2010-09 2011-04 Article http://purl.org/eprint/type/JournalArticle 1091-6490 http://hdl.handle.net/1721.1/70020 Jewell, C. M., S. C. Bustamante Lopez, and D. J. Irvine. “In Situ Engineering of the Lymph Node Microenvironment via Intranodal Injection of Adjuvant-releasing Polymer Particles.” Proceedings of the National Academy of Sciences 108.38 (2011): 15745–15750. en_US http://dx.doi.org/10.1073/pnas.1105200108 Proceedings of the National Academy of Sciences Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use. application/pdf National Academy of Sciences PNAS |
| spellingShingle | Jewell, Christopher M. Irvine, Darrell J Bustamante Lopez, Sandra C In situ engineering of the lymph node microenvironment via intranodal injection of adjuvant-releasing polymer particles |
| title | In situ engineering of the lymph node microenvironment via intranodal injection of adjuvant-releasing polymer particles |
| title_full | In situ engineering of the lymph node microenvironment via intranodal injection of adjuvant-releasing polymer particles |
| title_fullStr | In situ engineering of the lymph node microenvironment via intranodal injection of adjuvant-releasing polymer particles |
| title_full_unstemmed | In situ engineering of the lymph node microenvironment via intranodal injection of adjuvant-releasing polymer particles |
| title_short | In situ engineering of the lymph node microenvironment via intranodal injection of adjuvant-releasing polymer particles |
| title_sort | in situ engineering of the lymph node microenvironment via intranodal injection of adjuvant releasing polymer particles |
| url | http://hdl.handle.net/1721.1/70020 |
| work_keys_str_mv | AT jewellchristopherm insituengineeringofthelymphnodemicroenvironmentviaintranodalinjectionofadjuvantreleasingpolymerparticles AT irvinedarrellj insituengineeringofthelymphnodemicroenvironmentviaintranodalinjectionofadjuvantreleasingpolymerparticles AT bustamantelopezsandrac insituengineeringofthelymphnodemicroenvironmentviaintranodalinjectionofadjuvantreleasingpolymerparticles |